THE PI3K/AKT1 PATHWAY ENHANCES STEADY STATE LEVELS OF FANCL

被引：0
|
作者：
Dao, Kim-Hien [1 ]
Rotelli, Michael [1 ]
Brown, Brieanna [1 ]
Yates, Jane [2 ]
Rantala, Juha [3 ]
Tognon, Cristina [1 ]
Tyner, Jeffrey [1 ,4 ]
Druker, Brian [1 ,5 ]
Bagby, Grover [1 ,2 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[2] VA Med Ctr, Northwest VA Canc Res Ctr, Portland, OR USA
[3] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA
[5] Howard Hughes Med Inst, Portland, OR USA
来源：
EXPERIMENTAL HEMATOLOGY | 2013年 / 41卷 / 08期
关键词：
D O I：
10.1016/j.exphem.2013.05.165
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [1] The PI3K/Akt1 pathway enhances steady-state levels of FANCL
    Dao, Kim-Hien T.
    Rotelli, Michael D.
    Brown, Brieanna R.
    Yates, Jane E.
    Rantala, Juha
    Tognon, Cristina
    Tyner, Jeffrey W.
    Druker, Brian J.
    Bagby, Grover C.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24 (16) : 2582 - 2592
  • [2] Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway
    Bortul, R
    Tazzari, PL
    Billi, AM
    Tabellini, G
    Mantovani, I
    Cappellini, A
    Grafone, T
    Martinelli, G
    Conte, R
    Martelli, AM
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (05) : 677 - 686
  • [3] O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway
    Zhang, Peng
    Wang, Chunli
    Ma, Tao
    You, Shengyi
    ONCOTARGETS AND THERAPY, 2015, 8 : 3305 - 3313
  • [4] SVHRP enhances neurogenesis through the PI3K/Akt pathway
    Li, S.
    Li, N.
    Ge, B.
    Wu, X.
    Peng, Y.
    Zhao, J.
    GLIA, 2019, 67 : E506 - E507
  • [5] PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation
    Tibes, Raoul
    Kornblau, Steven M.
    Qiu, Yihua
    Mousses, Spyro M.
    Robbins, Christiane
    Moses, Tracy
    Carpten, John D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (03) : 344 - 347
  • [6] Mutation Profiling of PI3K/AKT1/MTOR Pathway Genes in Breast Cancer Patients of Pakistan
    Iqbal, Muhammad Javed
    Shakoori, Farah Rauf
    Muneer, Bushra
    Shakoori, Abdul Rauf
    PAKISTAN JOURNAL OF ZOOLOGY, 2024, 56 (01) : 273 - 285
  • [7] Berberine Regulates Polarization of Macrophages: A Mechanistic Study Based on PI3K/Akt1 Signaling Pathway
    Chen, Y. S.
    Wang, T. T.
    Meng, Z. H.
    Shang, S. S.
    Zheng, J. M.
    Zong, Y. H.
    Si, C. Y.
    Liang, Y. Z.
    Guan, H. M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 : S65 - S66
  • [8] THE STEADY-STATE EXPRESSION LEVEL OF CONNEXIN43 IS MAINTAINED BY THE PI3K/AKT PATHWAY
    Bhattacharjee, Rajib
    Kaneda, Makoto
    Nakahama, Ken-ichi
    Morita, Ikuo
    JOURNAL OF VASCULAR RESEARCH, 2009, 46 : 84 - 84
  • [9] NMT1 Enhances the Stemness of NSCLC Cells by Activating the PI3K/AKT Pathway
    Zou, Wailong
    Zhang, Xinjun
    Wang, Yumin
    Yan, Lei
    Wu, Xiaorui
    Yang, Rui
    Li, Yulin
    Zhang, Jia
    Chen, Jichao
    PHARMACOLOGY, 2022, 107 (9-10) : 486 - 494
  • [10] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
12345